BNP Paribas Financial Markets’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.3M Buy
211,260
+106,120
+101% +$2.16M ﹤0.01% 1447
2025
Q1
$1.91M Buy
105,140
+42,509
+68% +$772K ﹤0.01% 1711
2024
Q4
$1.58M Buy
62,631
+34,450
+122% +$871K ﹤0.01% 1809
2024
Q3
$958K Buy
28,181
+21,013
+293% +$714K ﹤0.01% 1846
2024
Q2
$265K Sell
7,168
-48,876
-87% -$1.81M ﹤0.01% 2329
2024
Q1
$2.35M Sell
56,044
-80,557
-59% -$3.38M ﹤0.01% 1443
2023
Q4
$5.42M Buy
136,601
+44,878
+49% +$1.78M 0.01% 928
2023
Q3
$2.52M Buy
91,723
+40,966
+81% +$1.13M ﹤0.01% 1235
2023
Q2
$1.72M Sell
50,757
-40,826
-45% -$1.39M ﹤0.01% 1350
2023
Q1
$3.3M Buy
91,583
+55,721
+155% +$2M ﹤0.01% 1099
2022
Q4
$1.6M Sell
35,862
-38,909
-52% -$1.73M ﹤0.01% 1352
2022
Q3
$2.1M Buy
74,771
+64,865
+655% +$1.82M ﹤0.01% 1405
2022
Q2
$267K Buy
9,906
+6,125
+162% +$165K ﹤0.01% 2347
2022
Q1
$129K Sell
3,781
-10,809
-74% -$368K ﹤0.01% 2717
2021
Q4
$564K Buy
14,590
+5,970
+69% +$231K ﹤0.01% 2343
2021
Q3
$465K Buy
8,620
+7,110
+471% +$384K ﹤0.01% 2211
2021
Q2
$50.5K Buy
1,510
+1,189
+370% +$39.8K ﹤0.01% 2668
2021
Q1
$6.61K Buy
321
+318
+10,600% +$6.55K ﹤0.01% 3283
2020
Q4
$53 Hold
3
﹤0.01% 3422
2020
Q3
$44 Hold
3
﹤0.01% 3514
2020
Q2
$39 Sell
3
-21
-88% -$273 ﹤0.01% 3605
2020
Q1
$40 Hold
24
﹤0.01% 3627
2019
Q4
$54 Sell
24
-232
-91% -$522 ﹤0.01% 3688
2019
Q3
$545 Sell
256
-18
-7% -$38 ﹤0.01% 3771
2019
Q2
$734 Buy
+274
New +$734 ﹤0.01% 3755
2019
Q1
Sell
-255
Closed -$756 3688
2018
Q4
$756 Buy
255
+74
+41% +$219 ﹤0.01% 3279
2018
Q3
$1.23K Hold
181
﹤0.01% 3635
2018
Q2
$1.37K Sell
181
-1,709
-90% -$12.9K ﹤0.01% 3629
2018
Q1
$66.1K Sell
1,890
-62
-3% -$2.17K ﹤0.01% 2826
2017
Q4
$83.1K Buy
1,952
+866
+80% +$36.9K ﹤0.01% 2745
2017
Q3
$46.6K Sell
1,086
-258
-19% -$11.1K ﹤0.01% 2724
2017
Q2
$49.8K Buy
1,344
+665
+98% +$24.6K ﹤0.01% 2720
2017
Q1
$36.8K Sell
679
-6,751
-91% -$366K ﹤0.01% 2392
2016
Q4
$395K Sell
7,430
-2,376
-24% -$126K ﹤0.01% 1541
2016
Q3
$594K Buy
9,806
+2,324
+31% +$141K ﹤0.01% 1136
2016
Q2
$493K Sell
7,482
-1,522
-17% -$100K ﹤0.01% 1520
2016
Q1
$511K Buy
9,004
+368
+4% +$20.9K ﹤0.01% 1198
2015
Q4
$2.03M Buy
8,636
+584
+7% +$137K ﹤0.01% 905
2015
Q3
$1.27M Buy
8,052
+4,130
+105% +$653K ﹤0.01% 974
2015
Q2
$1.48M Buy
3,922
+2,699
+221% +$1.02M ﹤0.01% 997
2015
Q1
$511K Sell
1,223
-1,409
-54% -$589K ﹤0.01% 1306
2014
Q4
$721K Sell
2,632
-5,200
-66% -$1.42M ﹤0.01% 1038
2014
Q3
$1.52M Buy
7,832
+5,138
+191% +$999K ﹤0.01% 1005
2014
Q2
$660K Buy
2,694
+1,854
+221% +$454K ﹤0.01% 1181
2014
Q1
$189K Buy
840
+764
+1,005% +$172K ﹤0.01% 1569
2013
Q4
$27.6K Sell
76
-1,415
-95% -$514K ﹤0.01% 1711
2013
Q3
$792K Sell
1,491
-387
-21% -$206K ﹤0.01% 1075
2013
Q2
$440K Buy
+1,878
New +$440K ﹤0.01% 1420